1. Home
  2. BNTC vs PALI Comparison

BNTC vs PALI Comparison

Compare BNTC & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$11.40

Market Cap

411.4M

Sector

Health Care

ML Signal

HOLD

Logo Palisade Bio Inc.

PALI

Palisade Bio Inc.

HOLD

Current Price

$2.00

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTC
PALI
Founded
1995
1996
Country
United States
United States
Employees
N/A
14
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.4M
338.9M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
BNTC
PALI
Price
$11.40
$2.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$27.67
$11.29
AVG Volume (30 Days)
79.6K
3.2M
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
80.94
97.06
EPS
N/A
N/A
Revenue
N/A
$260,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1500.39
52 Week Low
$9.85
$0.55
52 Week High
$17.15
$2.86

Technical Indicators

Market Signals
Indicator
BNTC
PALI
Relative Strength Index (RSI) 43.68 50.98
Support Level $9.91 $1.57
Resistance Level $13.40 $2.18
Average True Range (ATR) 0.68 0.13
MACD -0.11 0.00
Stochastic Oscillator 38.12 48.35

Price Performance

Historical Comparison
BNTC
PALI

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About PALI Palisade Bio Inc.

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Share on Social Networks: